Growth in this market is mainly driven by technological advancements, increasing demand for self-injection devices, and the rising incidence of chronic diseases.
[238 Pages Report] The needle-free injection system market is projected to reach USD 272 million by 2026 from USD 124 million in 2021, at a CAGR of 17.0% from 2021 to 2026.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861
Report Scope and Market Segmentation:
Report Metric | Details |
Market Size Available for Years | 2019–2026 |
Base Year Considered | 2020 |
Forecast Period | 2022–2026 |
Forecast Units | Value (USD Billion) |
Segments Covered | By Product Type, Application, products, Technology, Site of delivery, End User and Region |
Geographies Covered | North America, Europe, APAC, Latin America and Middle East & Africa |
Companies Covered | PharmaJet (US), Portal Instruments (US), Medical International Technology, Inc (MIT) (US), NuGen Medical Devices (Canada), Crossject SA (US), Bioject Medical Technologies (US) among others. |
Fillable segment accounted for the largest share in the needle-free injection system market.
Based on applications, the needle-free injection system market is segmented into vaccine delivery, insulin delivery, oncology, pain management, dermatology, and other applications. vaccine delivery is estimated to account for the largest share of 32.8% of the needle-free injection system market by application.
liquid-based injectors segment accounted for the largest share in the needle-free injection system market.
Based on the type, the needle-free injection system market is segmented into liquid-based, powder-based and projectile/depot-based needle-free injectors. The liquid-based segment accounted for the largest share of 70.9% of the needle-free injection system market
North America accounted segment accounted for the largest share in the needle-free injection system market.
On the basis of region, the needle-free injection system market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of 58% of the needle-free injection market, followed by Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa. However, the APAC region is expected to grow at the highest CAGR of 18.7% during the forecast period.
PHARMAJET
PharmaJet held the first position in the needle-free injection system market in 2020. PharmaJet is a leading provider of needle-free injectors. The company has developed PharmaJet Needle-free devices that deliver pharmaceuticals, vaccines, and liquid injectables through the skin, accomplished by the use of jet injection technology.
Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=165815861
